Trial Radar
Sign in

NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Asciminib Prospective Non Interventional Study as 3rd Line Therapy or More to Treat Adult Patients With CML- CP in Real World Setting in France
Asciminib Prospective Non Interventional Study as 3rd Line Therapy or More to Treat Adult Patients With CML- CP in Real World Setting in France

NCT06092879

Active Not RecruitingN/A

Sponsor: Novartis Pharmaceuticals

Conditions: Chronic Myeloid Leukemia

Interventions: Asciminib

Countries: France

The purpose of this study is to enhance the knowledge on asciminib treatment in a broader and real-life population by collecting additional data to characterize the treatment patterns of patients treated with asciminib, with a primary objective represented by maintenance on treatment at 12 months.

Eligibility overview

Sex: ALL

Age: 18 Years to 99 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

1. Patient aged ≥ 18 years at inclusion,
2. Patient with Ph+ CML-CP previously treated with two or more TKIs,
3. Patient for whom a decision has been taken by the treating physician (investigator) to initiate treatment with asciminib according to his own practice, the drug label / Summary of Product Characteristics (SmPC), and regardless of study participation,
4. Patient having given their non objection to participate to the study

Exclusion Criteria:

1. Patient with CML in accelerated phase (AP) or blastic phase (BP) at enrolment,
2. Patient with known history of T315I mutation,
3. Patient who previously received asciminib treatment,
4. Patient currently participating to an interventional clinical trial,
5. Patient with known contra-indication to asciminib according to the SmPC.
Locations (52)
  • Angers, France, France
  • Limoges, Haute Vienne, France
  • Saint Priest Jarez, Pays de la Loire Region, France
  • Aix-en-Provence, France
  • Amiens, France
  • Antibes, France
  • Avignon, France
  • Besançon, France
  • Bobigny, France
  • Bordeaux, France
  • Bordeaux, France
  • Brest, France
  • Brive-la-Gaillarde, France
  • Caen, France
  • Cagnes-sur-Mer, France
  • Cannes, France
  • Castelnau-le-Lez, France
  • Cesson-Sévigné, France
  • Chambéry, France
  • Clermont-Ferrand, France
  • Corbeil-Essonnes, France
  • Dunkirk, France
  • Essey-lès-Nancy, France
  • Grenoble, France
  • Le Kremlin-Bicêtre, France
  • Le Mans, France
  • Lens, France
  • Libourne, France
  • Lorient, France
  • Lyon, France
  • + 22 more on CT.gov